Preoperative Optimization of Crohn's Disease

 

 Buy Article Permissions and Reprints

ABSTRACT

Patients with Crohn's disease often present to the surgeon for operative intervention in poor overall condition. They may be taking multiple immunomodulators to attempt to manage their disease, may have significant weight loss and evidence of malnutrition, and 10 to 30% of the time will have intraabdominal sepsis in the form of an abscess or fistula. Preoperative optimization of these patients, when possible, may decrease morbidity and mortality, and may avoid formation of stomas for fecal diversion. Enhancing nutritional status and streamlining immunomodulator therapy prior to surgery may improve outcomes. Medical management of intraabdominal sepsis with percutaneous drainage of abdominal or pelvic abscesses may decrease postoperative septic complications, and may even avert the need for surgical intervention altogether.

REFERENCES

• 1 Tay G S, Binion D G, Eastwood D, Otterson M F. Multivariate analysis suggests improved perioperative outcome in Crohn's disease patients receiving immunomodulator therapy after segmental resection and/or strictureplasty.  Surgery. 2003;  134(4) 565-572 discussion 572-563
  CrossrefPubMedGoogle Scholar
• 2 Colombel J F, Loftus Jr E V, Tremaine W J et al.. The safety profile of infliximab in patients with Crohn's disease: the Mayo clinic experience in 500 patients.  Gastroenterology. 2004;  126(1) 19-31
  CrossrefPubMedGoogle Scholar
• 3 Yamamoto T, Allan R N, Keighley M R. Risk factors for intra-abdominal sepsis after surgery in Crohn's disease.  Dis Colon Rectum. 2000;  43(8) 1141-1145
  PubMedGoogle Scholar
• 4 Marchal L, D'Haens G, Van Assche G et al.. The risk of post-operative complications associated with infliximab therapy for Crohn's disease: a controlled cohort study.  Aliment Pharmacol Ther. 2004;  19(7) 749-754
  CrossrefPubMedGoogle Scholar
• 5 Mor I, Sherr B. Infliximab in ulcerative colitis is associated with an increased risk of postoperative complications after restorative proctocolectomy.  Dis Colon Rectum. 2007;  50(5) 734
  PubMedGoogle Scholar
• 6 Selvasekar C R, Cima R R, Larson D W et al.. Effect of infliximab on short-term complications in patients undergoing operations for chronic ulcerative colitis.  J Am Coll Surg. 2007;  204(5) 956-963
  CrossrefPubMedGoogle Scholar
• 7 Mantzoros I KI, Angelopoulos S, Koliakos G et al.. The effect of insulin-like growth factor I on healing of colonic anastomoses in cortisone-treated rats.  Dis Colon Rectum. 2006;  49 1431-1438
  CrossrefPubMedGoogle Scholar
• 8 Howarth GSCJ, Bourne A J, Ballard F J, Read L C. Insulin-like growth factor-I (IGF-I) stimulates regrowth of the damaged intestine in rats, when administered following, but not concurrent with methotrexate.  Growth Factors. 1998;  15 279-292
  PubMedGoogle Scholar
• 9 Evans J P, Steinhart A H, Cohen Z, McLeod R S. Home total parenteral nutrition: an alternative to early surgery for complicated inflammatory bowel disease.  J Gastrointest Surg. 2003;  7(4) 562-566
  CrossrefPubMedGoogle Scholar
• 10 Lashner B A, Evans A A, Hanauer S B. Preoperative total parenteral nutrition for bowel resection in Crohn's disease.  Dig Dis Sci. 1989;  34(5) 741-746
  CrossrefPubMedGoogle Scholar
• 11 Seo M, Okada M, Yao T, Furukawa H, Matake H. The role of total parenteral nutrition in the management of patients with acute attacks of inflammatory bowel disease.  J Clin Gastroenterol. 1999;  29(3) 270-275
  CrossrefPubMedGoogle Scholar
• 12 Alves A, Panis Y, Bouhnik Y, Pocard M, Vicaut E, Valleur P. Risk factors for intra-abdominal septic complications after a first ileocecal resection for Crohn's disease: a multivariate analysis in 161 consecutive patients.  Dis Colon Rectum. 2007;  50(3) 331-336
  CrossrefPubMedGoogle Scholar
• 13 Fasth S, Hulten L, Magnusson O, Nordgren S, Warnold I. The immediate and long-term effects of postoperative total parenteral nutrition on body composition.  Int J Colorectal Dis. 1987;  2(3) 139-145
  CrossrefPubMedGoogle Scholar
• 14 Sahai A, Belair M, Gianfelice D, Cote S, Gratton J, Lahaie R. Percutaneous drainage of intra-abdominal abscesses in Crohn's disease: short and long-term outcome.  Am J Gastroenterol. 1997;  92(2) 275-278
  PubMedGoogle Scholar
• 15 Gutierrez A, Lee H, Sands B E. Outcome of surgical versus percutaneous drainage of abdominal and pelvic abscesses in Crohn's disease.  Am J Gastroenterol. 2006;  101(10) 2283-2289
  CrossrefPubMedGoogle Scholar
• 16 Golfieri R, Cappelli A, Giampalma E et al.. CT-guided percutaneous pelvic abscess drainage in Crohn's disease.  Tech Coloproctol. 2006;  10(2) 99-105
  CrossrefPubMedGoogle Scholar
• 17 Harisinghani M G, Gervais D A, Maher M M et al.. Transgluteal approach for percutaneous drainage of deep pelvic abscesses: 154 cases.  Radiology. 2003;  228(3) 701-705
  PubMedGoogle Scholar
• 18 Gervais D A, Hahn P F, O'Neill M J, Mueller P R. Percutaneous abscess drainage in Crohn disease: technical success and short- and long-term outcomes during 14 years.  Radiology. 2002;  222(3) 645-651
  CrossrefPubMedGoogle Scholar
• 19 Jawahari A, Kamm M A, Ong C, Forbes A, Bartram C I, Hawley P R. Intra-abdominal and pelvic abscess in Crohn's disease: results of noninvasive and surgical management.  Br J Surg. 1998;  85(3) 367-371
  CrossrefPubMedGoogle Scholar
• 20 Ayuk P, Williams N, Scott N A, Nicholson D A, Irving M H. Management of intra-abdominal abscesses in Crohn's disease.  Ann R Coll Surg Engl. 1996;  78(1) 5-10
  PubMedGoogle Scholar
• 21 Rypens F, Dubois J, Garel L, Deslandres C, Saint-Vil D. Percutaneous drainage of abdominal abscesses in pediatric Crohn's disease.  AJR Am J Roentgenol. 2007;  188(2) 579-585
  CrossrefPubMedGoogle Scholar
• 22 Lee H, Kim Y H, Kim J H et al.. Nonsurgical treatment of abdominal or pelvic abscess in consecutive patients with Crohn's disease.  Dig Liver Dis. 2006;  38(9) 659-664
  CrossrefPubMedGoogle Scholar
• 23 Guenaga K, Atallah A N, Castro A A, Matos D DM, Wille-Jorgensen P. Mechanical bowel preparation for elective colorectal surgery.  Cochrane Database Syst Rev. 2005;  1 CD001544
  PubMedGoogle Scholar
• 24 Slim K, Vicault E, Panis Y, Chipponi J. Meta-analysis of randomized clinical trials of colorectal surgery with or without mechanical bowel preparation.  Br J Surg. 2004;  91 1125-1130
  CrossrefPubMedGoogle Scholar
• 25 Brownson P, Jenkins S, Nott D et al. Mechanical bowel preparation before colorectal surgery: results of a prospective randomized trial.  Br J Surg. 1992;  79 461-462
  PubMedGoogle Scholar
• 26 Burke P, Mealy K, Gillen P, Joyce W, Traynor O, Hyland J. Requirement for bowel preparation in colorectal surgery.  Br J Surg. 1994;  81 907-910
  PubMedGoogle Scholar
• 27 Santos Jr J CMBJ, Sirimarco M T, Guimaraes A S, Levy C E. Prospective randomized trial of mechanical bowel preparation in patients undergoing elective colorectal surgery.  Br J Surg. 1994;  81 1673-1676
  PubMedGoogle Scholar
• 28 Miettinen R P, Laitinen S T, Makela J T, Paakkonen M E. Bowel preparation with oral polyethylene glycol electrolyte solution vs. no preparation in elective open colorectal surgery: prospective randomized study.  Dis Colon Rectum. 2000;  43(5) 669-675
  CrossrefPubMedGoogle Scholar
• 29 Fillmann E EPFH, Filmann LS. Elective colorectal surgery without prepare.  Revista Brasileira de Coloproctologia. 1995;  15(2) 70-71
  PubMedGoogle Scholar
• 30 Zmora O, Mahajna A, Bar-Zakai B et al.. Colon and rectal surgery without mechanical bowel preparation: a randomized prospective trial.  Ann Surg. 2003;  237(3) 363-367
  CrossrefPubMedGoogle Scholar
• 31 Fa-Si-Oen P RBJ, van Geldere D, deWaard J W et al.. The effect of preoperative bowel preparation with polyethylene glycol on surgical outcome in elective colorectal surgery-a randomized multicentre trial. Abstract presented at: the Fourth Belgian Surgical Week 2003 Ostnede, Belgium;
  Google Scholar

Jonathan E EfronM.D. 

Division of Colon and Rectal Surgery, Mayo Clinic

1340 E. Shea Blvd., Scottsdale, AZ 85259

Email: efron.jonathan@mayo.edu